The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1555
September 10, 2018
View Complete Issue         Table of Contents 2019 
Imvexxy - Another Estradiol Vaginal Insert for Dyspareunia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Imvexxy - Another Estradiol Vaginal Insert for Dyspareunia
September 10, 2018 (Issue: 1555)
The FDA has approved an estradiol softgel vaginal insert (Imvexxy – TherapeuticsMD) for treatment of postmenopausal women with moderate to severe dyspareunia due to vulvovaginal atrophy (VVA). Imvexxy is the second estradiol vaginal insert to...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Imvexxy - Another Estradiol Vaginal Insert for Dyspareunia
Article code: 1555b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.